News
The US Food and Drug Administration will require all new vaccines go through placebo-controlled studies before they are ...
Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...
Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...
The FDA may be making changes to how it handles COVID-19 booster shots. The agency’s top official says they’re taking a ...
The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine -- the nation's only traditional ...
Novavax's protein-only vaccine is once again expected to move from emergency approval to full approval status following a pause.
As GSK weathers the storm of sinking vaccine sales and gears up for key launches in its specialty medicines sector, the ...
Comments over the weekend by FDA chief Martin Makary suggest the agency views Novavax’s updated COVID shot as a “new product” ...
FDA vaccine oversight is shifting, with increased scrutiny and mixed messaging sparking concerns among health experts.
We’d like to introduce you to the fellow above, whose name is Jae. When asked what area of study she specializes in, she only ...
On Wednesday, the company got word that the FDA would consider approving the vaccine, provided Novavax agrees to produce additional clinical data on the vaccine's efficacy following its approval.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results